Surgical Science (Sweden) Performance
| SUS Stock | SEK 148.50 2.40 1.64% |
On a scale of 0 to 100, Surgical Science holds a performance score of 7. The entity has a beta of 0.0238, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Surgical Science's returns are expected to increase less than the market. However, during the bear market, the loss of holding Surgical Science is expected to be smaller as well. Please check Surgical Science's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Surgical Science's existing price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Surgical Science unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 87.2 M | |
| Total Cashflows From Investing Activities | -2.7 B |
Surgical |
Surgical Science Relative Risk vs. Return Landscape
If you would invest 12,600 in Surgical Science Sweden on August 28, 2024 and sell it today you would earn a total of 2,250 from holding Surgical Science Sweden or generate 17.86% return on investment over 90 days. Surgical Science Sweden is generating 0.2997% of daily returns assuming 2.9916% volatility of returns over the 90 days investment horizon. Simply put, 26% of all stocks have less volatile historical return distribution than Surgical Science, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Surgical Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgical Science's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgical Science Sweden, and traders can use it to determine the average amount a Surgical Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1002
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SUS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.99 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Surgical Science is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgical Science by adding it to a well-diversified portfolio.
Surgical Science Fundamentals Growth
Surgical Stock prices reflect investors' perceptions of the future prospects and financial health of Surgical Science, and Surgical Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgical Stock performance.
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 7.68 B | |||
| Shares Outstanding | 50.8 M | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 10.66 X | |||
| Revenue | 366.78 M | |||
| EBITDA | 122.27 M | |||
| Cash And Equivalents | 316.68 M | |||
| Cash Per Share | 8.15 X | |||
| Total Debt | 160.68 M | |||
| Book Value Per Share | 85.75 X | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 2.65 X | |||
| Total Asset | 3.98 B | |||
About Surgical Science Performance
Assessing Surgical Science's fundamental ratios provides investors with valuable insights into Surgical Science's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Surgical Science is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.Things to note about Surgical Science Sweden performance evaluation
Checking the ongoing alerts about Surgical Science for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgical Science Sweden help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 33.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Surgical Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgical Science's stock is overvalued or undervalued compared to its peers.
- Examining Surgical Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgical Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgical Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgical Science's stock. These opinions can provide insight into Surgical Science's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.